SCHEMBL7187449

SCHEMBL7187449

CCCc1cc(CCC)c(OCC)c(C=CC(=O)c2ccc(O)cc2)c1O

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAOB P27338 5/20 0.51
ABCG2 Q9UNQ0 4/20 0.51
LMNA P02545 2/20 0.44
POLB P06746 1/20 0.44
CYP1A1 P04798 3/20 0.42
CYP1B1 Q16678 3/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2D6 P10635 2/20 0.42
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAOA P21397 1/20 0.41
CAPN1 P07384 1/20 0.41
CTSL P07711 1/20 0.41
CTSB P07858 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
F3 P13726 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7187442 1.00 MAOB (0.51) MAOBABCG2LMNAPOLBCYP1A1
SCHEMBL7184788 0.92 ABCG2 (0.54) MAOBABCG2LMNAPOLBCYP1A1
SCHEMBL7184784 0.92 ABCG2 (0.54) MAOBABCG2LMNAPOLBCYP1A1
SCHEMBL7180148 0.91 CA1 (0.43) MAOBABCG2LMNACYP1A1CYP1B1
SCHEMBL7180145 0.91 CA1 (0.43) MAOBABCG2LMNACYP1A1CYP1B1
SCHEMBL7179097 0.89 CTSL (0.47) MAOBABCG2ALDH1A1MAPTCAPN1
SCHEMBL7179100 0.89 CTSL (0.47) MAOBABCG2ALDH1A1MAPTCAPN1
SCHEMBL7192265 0.89 MAOB (0.54) MAOBABCG2LMNAPOLBCYP1A1
SCHEMBL7192261 0.89 MAOB (0.54) MAOBABCG2LMNAPOLBCYP1A1
SCHEMBL7185214 0.89 MAOB (0.40) MAOBABCG2LMNACYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed